Pulmonary hypertension in idiopathic pulmonary fibrosis: Prevalence and clinical progress

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 681-689

  Castria, D ^a   Refini, R M ^a   Bargagli, E ^a   Mezzasalma, F ^a   Pierli, C ^b   Rottoli, P ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Idiopathic pulmonary fibrosis; Prevalence; Pulmonary hypertension

Indexed keywords

ARTICLE; DISEASE COURSE; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL TIME;

EID: 84868013322     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500314     Document Type: Article

References (30)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; 30( 20): 2493-537.
2. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ ERS/JRS/ALAT Statement. Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011; 183( 6): 788-824.
3. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128(4):2393-9. (Pubitemid 41507585)
4. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007; 30(4):715-21. (Pubitemid 351194832)
5. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced pulmonary fibrosis. Chest 2006; 129( 3): 746-52
6. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007; 132( 3): 998-1006
7. Modrykamien AM, Gudavalli R, McCarthy K, Parambil J. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care 2010; 55( 5): 584-8.
8. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131(3):657-63. (Pubitemid 46446854)
9. Nathan SD, Shlobin OA, Ahmad S, Koch J, Barnett SD, Ad N, Burton N, Leslie K. Serial Development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008; 76( 3): 288-94.
10. Papakosta D, Pitsiou G, Daniil Z, et al. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters. Lung 2011; 189( 5): 391-9.
11. Harari S, Simonneau G, De Juli E, et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J Heart Lung Transplant 1997; 16(4):460-3. (Pubitemid 27199604)
12. Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias. Intern Med 2007; 46(12):831-7. (Pubitemid 47263380)
13. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 2002; 201 (4):335-48. (Pubitemid 35244053)
14. Tuder RM, Cool CD, Yeager M, TarasevicieneStewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension: endothelium. Clin Chest Med 2001; 22(3):405-18. (Pubitemid 32916102)
15. Tachihara A, Jin E, Matsuoka T, Ghazizadeh M, Yoshino S, Takemura T, D Travis W, Kawanami O. Critical roles of capillary endothelial cells for alveolar remodelling in non specific and usual interstitial pneumonias. J Nihon Med Sch 2006; 73(4):203-13. (Pubitemid 44274095)
16. Gagermeier J, Dauber J, Yousem S, Gibson K, Kaminski N. Abnormal vascular henotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension. Chest 2005; 128( 5): 6015.
17. Renzoni EA, Walsh DA, Salmon M, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir CritCare Med 2003; 167( 3): 438-43.
18. Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. Pulmonary hypertension in patients with interstitial lung disease. Mayo Clin Proc 2007; 82(3):342-50. (Pubitemid 46348935)
19. Swanson KL, Utz JP, Krowka MJ. Doppler echocardiography - right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit 2008; 14( 4): 177-82.
20. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131(3):650-6. (Pubitemid 46446853)
21. Pitsiou G, Papakosta D, Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Repiration 2011; 82: 294-304.
22. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. European Respiratory Journal 2005; 26(4):586-93. (Pubitemid 41448654)
23. Mej'ia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136( 1): 10-15.
24. Macintyre N, Crapo RO, Viegi G, et al. Standardization of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26 (4):720-35. (Pubitemid 41448672)
25. Wanger J, Clausen JL, Coates A, et al. Standardization of the measurement of lung volumes. Eur Respir J 2005; 26( 3): 511-22.
26. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166( 1): 111-17.
27. Bland JM, Altman DG: Statistical methods for assessing agreement between two measures of clinical measurement. Lancet 1986; 84: 307-10. (Pubitemid 16134762)
28. Todd NW, Lavania S, Park MH, et al. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. J Heart Lung Transplant 2010; 29( 2): 188-94.
29. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis. Scoring System and Survival Model. Am J Respir Crit Care Med 2001; 164( 7): 1171 -
30. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137( 2): 376-87.